168 related articles for article (PubMed ID: 17905528)
1. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.
Rades D; Stoehr M; Kazic N; Hakim SG; Walz A; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1108-14. PubMed ID: 17905528
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.
Huttenlocher S; Seibold ND; Gebhard MP; Noack F; Thorns C; Hasselbacher K; Wollenberg B; Schild SE; Rades D
Strahlenther Onkol; 2014 Oct; 190(11):1021-7. PubMed ID: 24928249
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor expression: prognostic value in locally advanced squamous cell carcinoma of the head and neck.
Rades D; Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F
Strahlenther Onkol; 2013 Oct; 189(10):849-55. PubMed ID: 23959264
[TBL] [Abstract][Full Text] [Related]
4. Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
Rades D; Huttenlocher S; Seibold ND; Gebhard MP; Thorns C; Hasselbacher K; Wollenberg B; Schild SE
BMC Cancer; 2015 Mar; 15():102. PubMed ID: 25868613
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Rades D; Seibold ND; Gebhard MP; Noack F; Schild SE; Thorns C
Strahlenther Onkol; 2011 Oct; 187(10):626-32. PubMed ID: 21932027
[TBL] [Abstract][Full Text] [Related]
6. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
Lee WR; Berkey B; Marcial V; Fu KK; Cooper JS; Vikram B; Coia LR; Rotman M; Ortiz H
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1069-75. PubMed ID: 9869231
[TBL] [Abstract][Full Text] [Related]
7. Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.
Rades D; Meyners T; Kazic N; Bajrovic A; Rudat V; Schild SE
Strahlenther Onkol; 2011 Sep; 187(9):541-7. PubMed ID: 21858415
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck.
Rades D; Seibold ND; Gebhard MP; Noack F; Bruchhage KL; Schild SE
Strahlenther Onkol; 2014 Jan; 190(1):68-74. PubMed ID: 23861152
[TBL] [Abstract][Full Text] [Related]
9. The effect of low hemoglobin levels on outcomes of radiotherapy following microscopically complete resection of locally advanced SCCHN: Implications for the future.
Rades D; Seidl D; Janssen S; Wollenberg B; Hakim SG; Schild SE
J Craniomaxillofac Surg; 2016 Sep; 44(9):1441-4. PubMed ID: 27470216
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.
Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F; Rades D
Strahlenther Onkol; 2013 Aug; 189(8):639-46. PubMed ID: 23748230
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck. Impact of tumor cell expression of EPO and EPO-R.
Seibold ND; Schild SE; Gebhard MP; Noack F; Schröder U; Rades D
Strahlenther Onkol; 2013 Jul; 189(7):559-65. PubMed ID: 23700207
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
Rades D; Setter C; Dahl O; Schild SE; Noack F
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Rudat V; Dietz A; Schramm O; Conradt C; Maier H; Flentje M; Wannenmacher M
Radiother Oncol; 1999 Nov; 53(2):119-25. PubMed ID: 10665788
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
16. Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
Katahira-Suzuki R; Hata M; Tateishi U; Taguchi T; Takano S; Omura-Minamisawa M; Inoue T
Ann Nucl Med; 2015 Jan; 29(1):37-45. PubMed ID: 25228378
[TBL] [Abstract][Full Text] [Related]
17. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
[TBL] [Abstract][Full Text] [Related]
18. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.
Rades D; Fehlauer F; Wroblesky J; Albers D; Schild SE; Schmidt R
Oral Oncol; 2007 Jul; 43(6):535-43. PubMed ID: 17005437
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
